GMP Facility
The facility was jointly funded by Ïã¸ÛÁùºÏ²Ê and the University College London Hospitals Biomedical Research Centre. The state-of-the-art unit was established in 2016, and licensed by the MHRA in 2017 (Specials’ and Investigational Medicinal Products). We specialize in the manufacture of radiotracers with short-lived nuclides as well as bespoke diagnostic agents for cutting-edge imaging techniques, including hyperpolarised magnetic resonance imaging (MRI). The facility supports translational experimental medicine studies across Ïã¸ÛÁùºÏ²Ê, Ïã¸ÛÁùºÏ²Ê Hospitals and a number of collaborating institutions in South East England.